Article
Body mass index, leptin and leptin receptor polymorphisms, and non-hodgkin lymphoma.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 May 2004
Skibola Christine F, Holly Elizabeth A, Forrest Matthew S, Hubbard Alan, Bracci Paige M, Skibola Danica R, Hegedus Christine, Smith Martyn T
Abstract excerpt
In a population-based case-control study, obesity was associated with elevated odds ratios (ORs) for non-Hodgkin lymphoma (NHL), and the two major subtypes, diffuse large cell (DLCL) and follicular lymphoma (FL). Those who were obese (body mass index >/= 30) were up to three times more likely to develop NHL or its major subtypes than persons with body mass index of 20 to <25. Obesity-related genetic factors...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
